glp 1 glucagon dual receptor agonist Effects, working principles and target tissues of agonists LY3437943, a novel triple glucagon,

HLCMHPP2023086)

Available in 2mg, 5mg and 10mg vials

These include regulation of mechanisms controlling reactive oxygen species (ROS), which cause macromolecular damage 16,17 , mitochondrial turnover or mitophagy 18 , and the mitochondrial unfolded protein response (UPR mt ), in which mitochondrial damage can be prevented by the removal of aggregated or unfolded proteins 19

Additionally, lack of treatment for other precipitating factors involved in the development of HE, such as oxidative stress, inflammation or other cerebral alterations, is a major limiting step in the treatment area

doi: 10.1210/en.2007-1292 46 KimJYLeeSKJoKJSongDYLimDMParkKYet al

PubMed For laboratory and research use only